APA (7th ed.) Citation

Cox, T. M., Drelichman, G., Cravo, R., Balwani, M., Burrow, T. A., Martins, A. M., . . . Puga, A. C. (2014). ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals. Molecular Genetics & Metabolism, 111(2), S33. https://doi.org/10.1016/j.ymgme.2013.12.061

Chicago Style (17th ed.) Citation

Cox, Timothy M., et al. "ENCORE: A Randomized, Controlled, Open-label Non-inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients on Enzyme Replacement Therapy Who Have Reached Therapeutic Goals." Molecular Genetics & Metabolism 111, no. 2 (2014): S33. https://doi.org/10.1016/j.ymgme.2013.12.061.

MLA (9th ed.) Citation

Cox, Timothy M., et al. "ENCORE: A Randomized, Controlled, Open-label Non-inferiority Study Comparing Eliglustat to Imiglucerase in Gaucher Disease Type 1 Patients on Enzyme Replacement Therapy Who Have Reached Therapeutic Goals." Molecular Genetics & Metabolism, vol. 111, no. 2, 2014, p. S33, https://doi.org/10.1016/j.ymgme.2013.12.061.